Popular Articles
Burdock Root

Biomodels' Oral Mucositis Expertise Speeds FDA Approval For ActoGeniX's Phase 1b Trial Of AGO13 In Cancer Patients
Biomodels LLC, a preclinical research organization specializing in cancer support care, announced that its customized research program allowed ActoGeniX NV, a development stage biopharmaceutical company, to rapidly attain Food and Drug Administration (FDA) approval for Phase 1b clinical trials of AGO13 in cancer patients with oral mucositis.
generic viagra online
Judges Can Make Poor Decisions About Asylum Seekers
Judges often make poor decisions about the stories asylum seekers tell them because their decisions are based on false assumptions.
News of the day
SAMe Is Effective In Preventing Formation Of Primary Liver Cancer In Rats
A new study investigated the effectiveness of S-adenosylmethionine (SAMe) in the prevention and treatment of hepatocellular carcinoma (HCC) or primary liver cancer. SAMe, a widely available nutritional supplement, with little known side effects, was found to be effective in preventing the formation of HCC in rats. However, high enough levels of SAMe were not attainable to successfully treat established HCC. The findings are available in the August issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases.
Medical Devices

Applied Infectious Disease Epidemiology Conference, Stockholm, Stockholm, October 26-28, 2009

"Epidemiology is always important and topical, though sometimes unsung," says Professor Johan Giesecke, Chief Scientist at ECDC, the European Centre for Disease Prevention and Control, "but the third applied Infectious Disease Epidemiology Conference in Stockholm in October this year will be an opportunity to put Epidemiology and infectious disease prevention and control into the spotlight; delegates will have the opportunity to discuss and share information on current and emerging infectious diseases, including influenza A (H1N1)v. The call for abstracts closes on July 3rd so there is no time to lose." "Let me stress," he adds, "that influenza is not the only topic. We welcome abstracts relating to all infectious diseases in areas of applied public health research, outbreak investigations and public health surveillance. We also welcome abstracts in other areas of applied epidemiology or public health practice in which results are linked to public health action. We have an easy-to-use online system for abstract submission and conference registration to be found at http://www.escaide.eu. And it is not to soon to register. Remember, Sweden has the Presidency of the EU in the second half of this year, so we advise you to book your flights and hotel early." The European Centre for Disease Prevention and Control - ECDC - will host the third annual European Scientific Conference on Applied Infectious Disease Epidemiology - ESCAIDE - in Stockholm, home to the ECDC, from October 26-28. The event is being organized in partnership with the European Programme for Intervention Epidemiology Training (EPIET) and the EPIET Alumni network (EAN). It is a unique opportunity for frontline professionals from national disease control institutes to engage with each other and the wider scientific community. The Conference aims at: - strengthening and expanding the network of all those involved in applied infectious disease epidemiology; - sharing scientific knowledge and experience in this field in Europe and internationally; and - providing a dedicated platform for fellows of the EPIET/FETP (field epidemiology training program) to present their work. ESCAIDE 2009 is expecting participation of up to 500 health experts from more than 60 countries. The application for ESCAIDE to be accredited by the European Accreditation Council for Continuing Medical Education (EACCME) as in 2008 is under way. This should enable participants to be granted up to a maximum of 18 CME credits for participating in the conference while the registration costs will remain low. More information can be found at http://www.escaide.eu ECDC Set up in 2005 and headquartered in Stockholm, the European Centre for Disease Prevention and Control (ECDC) is a EU agency which aims to strengthen Europe"s defences against infectious diseases. ECDC"s mission is to identify, assess and communicate current and emerging threats to human health posed by infectious diseases. In order to achieve its mission, ECDC works in partnership with national health protection bodies across Europe to strengthen and develop continent-wide disease surveillance and early warning systems. By working with experts throughout Europe, ECDC pools Europe"s health knowledge, so as to develop authoritative scientific opinions about the risks posed by current and emerging infectious diseases. EPIET EPIET is the European Programme for Intervention Epidemiology Training, which provides training and practical experience in intervention epidemiology at the national centres for surveillance and control of communicable diseases in the European Union (EU). Presentation of EPIET diplomas will be the closing event of the Conference. ECDC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):